Managingip.com14h
AI is transforming life sciences but raising risk concerns, new benchmark report finds
A new survey by Arnold & Porter reveals that AI adoption in life sciences is accelerating, driving innovation in drug ...
Managingip.com1h
‘Obvious gap to fill’: IP committee head on importance of representation
David Parrish expects AI to be among the major talking points for a newly formed committee aimed at protecting the interests ...
Managingip.com14h
Weighing ‘reasonable expectation of success’ in drug patent inventiveness assessments in China
Wu Xiaoping of Wanhuida Intellectual Property says the methodology often applied in assessing inventiveness in pharmaceutical ...